HALSTEAD MICHAEL enters HELUS PHARMA INC. with 68.57K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 9/17/2026ACC: 0000912282-26-001277
Officer· Chief Executive Officer
Since Sep 2026
68.57K
Baseline shares
100% direct
68.57K
Direct ownership
1 position
1.36M
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Shares
DirectShares owned68.57K
Total
68.57K direct68.57K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 68.57K | Direct |
| Total | 68.57K | 68.57K direct |
Derivative Holdings2
Performance Share Units
DirectUnderlying security
Common Stock
Underlying shares
283.33K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Restricted Share Units
DirectUnderlying security
Common Stock
Underlying shares
1.07M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
1.36M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Performance Share Units Direct | Common Stock | — | — | 283.33K | N/A | |
| Restricted Share Units Direct | Common Stock | — | — | 1.07M | N/A | |
| Total | 1.36M | 0.00 | ||||